NF-κB-dependent and -independent epigenetic modulation using the novel anti-cancer agent DMAPT.

43 With the TCGA breast cancer data set, higher expression of NSD1 showed a trend toward better overall survival when all tumor subtypes were considered ( Figure 6c ) and significant survival advantage in HER2-negative patients (135 high and 134 low expression cases, Figure 6d ).

also in 53,322 other papers